Blog

Russ Cohen

Most Popular

Exploring the Ongoing Saga of Nvidia Stock

A Dual Dance in Two Booming Markets Nvidia, often hailed as the tech marvel of the century, has been a rollercoaster of a stock. Its ascent to the pinnacle of the tech industry can be attributed to the soaring sales of artificial intelligence (AI) systems. The recent addition of Nvidia to the elite group known ...

Russ Cohen

Most Popular

Google’s Stock Surge – A Triumph Beyond Expectations Google’s Stock Surge – A Triumph Beyond Expectations

Google has recently emerged from a drawn-out consolidation period, indicating a remarkable shift in stock performance following its successful IPO in 2004. This recent market upswing hints at a potential milestone of $200 on the horizon.   Alphabet Inc Class A GOOGL has surged by 83%, breaking free from an extended phase of consolidation to ...

Russ Cohen

Most Popular

Revolutionizing Public Safety: Motorola’s P25 Radio System in Oakland County

In a game-changing move, Motorola Solutions Inc. has unveiled its cutting-edge P25 radio system deployment in Oakland County to enhance public safety and emergency response services. This innovative radio infrastructure not only empowers first responders in the region but also bridges communication barriers, fostering seamless coordination across multiple agencies. Transforming Communication Landscape With an investment ...

Russ Cohen

Most Popular

Analyzing Semiconductor Supply Chain Impact Post-Taiwan Earthquake Assessing the Fallout: How Taiwan’s Earthquake Rattled the Semiconductor Supply Chain

In a world where entire supply chains hinge on the stability of a single locale, the seismic tremors in Taiwan have sent ripples across the semiconductor sector. The quake, which registered a magnitude of 7.4, struck close to Taipei, leaving a trail of destruction in its wake but sparing the heart of chip manufacturing in ...

Russ Cohen

Most Popular

Simulations Plus Q2 Financial Performance Overview

Simulations Plus dazzled investors with its second-quarter fiscal 2024 earnings, matching year-over-year earnings at 20 cents per share, yet dazzling analysts by exceeding the Zacks Consensus Estimate by 11.1%. Robust Revenue Growth The company achieved a 16% year-over-year revenue increase to $18.3 million, driven by soaring software revenues in the Clinical Pharmacology & Pharmacometrics (CPP) ...